anmelden
OMX Nordic 40
2.733,09
PKT
+2,26
PKT
+0,08
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Nordic 40-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 19.02.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 19.02.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 18.02.25 | Hennes Mauritz (H M, H&M) Sell | Goldman Sachs Group Inc. | |
| 17.02.25 | Novo Nordisk Buy | UBS AG | |
| 17.02.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 13.02.25 | AstraZeneca Buy | UBS AG | |
| 12.02.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 12.02.25 | AstraZeneca Hold | Deutsche Bank AG | |
| 12.02.25 | Hennes Mauritz (H M, H&M) Hold | Deutsche Bank AG | |
| 12.02.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 11.02.25 | ABB (Asea Brown Boveri) Underperform | Bernstein Research | |
| 11.02.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 11.02.25 | AstraZeneca Outperform | Bernstein Research | |
| 11.02.25 | ABB (Asea Brown Boveri) Neutral | Goldman Sachs Group Inc. | |
| 10.02.25 | Novo Nordisk Buy | UBS AG | |
| 10.02.25 | Nokia Overweight | JP Morgan Chase & Co. | |
| 10.02.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 10.02.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 10.02.25 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 07.02.25 | AstraZeneca Halten | DZ BANK | |
| 07.02.25 | ABB (Asea Brown Boveri) Kaufen | DZ BANK | |
| 07.02.25 | Volvo (B) Sector Perform | RBC Capital Markets | |
| 07.02.25 | A.P. Moeller - Maersk A-S (B) Underperform | Bernstein Research | |
| 07.02.25 | AstraZeneca Hold | Deutsche Bank AG | |
| 07.02.25 | Novo Nordisk Buy | UBS AG | |
| 06.02.25 | Novo Nordisk Halten | DZ BANK | |
| 06.02.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 06.02.25 | AstraZeneca Neutral | UBS AG | |
| 06.02.25 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 06.02.25 | A.P. Moeller - Maersk A-S (B) Neutral | UBS AG | |
| 06.02.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 06.02.25 | Novo Nordisk Buy | UBS AG | |
| 06.02.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 05.02.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 05.02.25 | Novo Nordisk Buy | UBS AG | |
| 05.02.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 05.02.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 05.02.25 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 03.02.25 | Novo Nordisk Buy | UBS AG | |
| 03.02.25 | Volvo (B) Overweight | JP Morgan Chase & Co. |
